adenosine has been researched along with No-Reflow Phenomenon in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 13 (65.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aamaraee, Z; Mousavi, SH; Sadeghian, M; Shafiee, A | 1 |
| Bollati, M; Dall'Ara, G; Di Mario, C; Gasparini, GL; Grotti, S; Mattesini, A; Oreglia, JA; Tarantino, F; Testa, L; Tumscitz, C | 1 |
| Ali Seif Rabiei, M; Kanonisabet, A; Mozayanimonfared, A; Naghshtabrizi, B; Naghshtabrizi, N; Sajedi, M | 1 |
| Cohen, MG; Gulati, R; Kwan, T; Pancholy, S; Patel, T; Shah, S | 1 |
| Cenko, E; Manfrini, O; Scarpone, M | 1 |
| Araszkiewicz, A; Grajek, S; Grygier, M; Lesiak, M | 2 |
| Aung Naing, K; Li, L; Su, Q; Wu, T | 1 |
| Camici, PG; Colombo, A; Durante, A; Latib, A; Pizzetti, G | 1 |
| Arif Yalcin, A; Biyik, I; Celik, O; Erturk, M; Faruk Akturk, I; Murat Caglar, I; Oner, E; Sarikamis, C; Turhan Caglar, N; Uzun, F | 1 |
| Abrams, KR; Adgey, AA; Been, M; Blackman, DJ; Gershlick, AH; Greenwood, JP; Khan, JN; Kunadian, V; Mahmoud, IZ; McCann, GP; Nazir, SA; Wilcox, R | 1 |
| Li, L; Nyi, TS; Su, Q | 1 |
| Duncker, DJ; Falotico, R; Krabbendam-Peters, I; Manintveld, OC; Merkus, D; Serruys, PW; Te Lintel Hekkert, M; Uitterdijk, A; van Beusekom, HMM; van Geuns, RM; Yetgin, T; Zijlstra, F | 1 |
| Monassier, JP | 1 |
| Bartorelli, A; Cosentino, N; Crea, F; D'amario, D; De Vita, MR; Fabbiocchi, F; Ferrari, R; Imola, F; Marino, M; Niccoli, G; Prati, F; Rigattieri, S; Schiavo, PL; Spaziani, C; Tarantino, F; Valgimigli, M | 1 |
| Bernal, JM; Cubeddu, RJ; Don, CW; Kiernan, GD; Kiernan, TJ; Ruggiero, NJ; Witzke, C; Yan, BP | 1 |
| Crea, F; Marino, M; Niccoli, G; Spaziani, C | 1 |
| Ambler, K; Badulak, A; Bauerle, JD; Blackburn, MR; Brodsky, KS; Choi, DS; Christians, U; Clambey, E; Coe, IR; Dalton, JH; Eltzschig, HK; Grenz, A; Haase, VH; Klawitter, J; Lukashev, D; Magee, K; McNamee, EN; Moldovan, R; Nürnberg, B; Osswald, H; Ravid, K; Reyes, G; Ridyard, D; Sitkovsky, M; Tak, E; Wen, J; Xia, Y | 1 |
| Bertaso, AG; Leung, MC; Meredith, IT; Puri, R; Richardson, JD; Teo, KS; Williams, K; Wong, DT; Worthley, MI; Worthley, SG | 1 |
| Lee, KW; Norell, MS | 1 |
8 review(s) available for adenosine and No-Reflow Phenomenon
| Article | Year |
|---|---|
Coronary No-Reflow Phenomenon in Clinical Practice.
Topics: Adenosine; Coronary Vessels; Humans; Microcirculation; Nitroprusside; No-Reflow Phenomenon; Verapamil | 2018 |
Role of adenosine as an adjunct therapy in the prevention and treatment of no-reflow phenomenon in acute myocardial infarction with ST segment elevation: review of the current data.
Topics: Adenosine; Chemotherapy, Adjuvant; Humans; Myocardial Infarction; Myocardial Reperfusion; No-Reflow Phenomenon; Vasodilator Agents | 2013 |
Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
Topics: Adenosine; Cause of Death; Humans; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Vasodilator Agents; Verapamil | 2013 |
Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
Topics: Adenosine; Cause of Death; Humans; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Vasodilator Agents; Verapamil | 2015 |
Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.
Topics: Adenosine; Angioplasty, Balloon, Coronary; Animals; Coronary Circulation; Electrocardiography; Heart Conduction System; Humans; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Nicorandil; No-Reflow Phenomenon; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombectomy; Treatment Outcome; Vasodilator Agents | 2008 |
The no-reflow phenomenon in the coronary circulation.
Topics: Adenosine; Animals; Coronary Circulation; Diltiazem; Humans; Nicardipine; Nicorandil; Nitroprusside; No-Reflow Phenomenon; Prostheses and Implants; Vasodilator Agents; Verapamil | 2009 |
Prevention and treatment of no-reflow.
Topics: Abciximab; Adenosine; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Electrocardiography; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Myocardial Reperfusion; No-Reflow Phenomenon; Thrombectomy; Treatment Outcome; Verapamil | 2010 |
Management of 'no-reflow' complicating reperfusion therapy.
Topics: Acute Coronary Syndrome; Adenosine; Angioplasty, Balloon, Coronary; Balloon Occlusion; Coronary Angiography; Diagnosis, Differential; Filtration; Humans; Myocardial Reperfusion; Nitroprusside; No-Reflow Phenomenon; Prostheses and Implants; Vasodilator Agents; Verapamil | 2008 |
6 trial(s) available for adenosine and No-Reflow Phenomenon
| Article | Year |
|---|---|
Administration of intracoronary adenosine before stenting for the prevention of no-reflow in patients with ST-elevation myocardial infarction.
Topics: Adenosine; Aged; Humans; Male; Middle Aged; No-Reflow Phenomenon; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Stents | 2022 |
Randomized trial of intracoronary adenosine as adjunctive therapy for prevention of the no-reflow phenomenon.
Topics: Adenosine; Coronary Angiography; Coronary Circulation; Coronary Vessels; Follow-Up Studies; Humans; Injections, Intra-Arterial; No-Reflow Phenomenon; Prognosis; Prospective Studies; Single-Blind Method; Vasodilator Agents; Ventricular Function, Left | 2020 |
Intracoronary adenosine administered during aortocoronary vein graft interventions may reduce the incidence of no-reflow phenomenon. A pilot randomised trial.
Topics: Adenosine; Aged; Aged, 80 and over; Female; Humans; Male; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Primary Graft Dysfunction; Prospective Studies; Saphenous Vein; Vasodilator Agents | 2014 |
Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction.
Topics: Adenosine; Aged; Female; Fibrinolytic Agents; Follow-Up Studies; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Prognosis; Prospective Studies; Survival Rate; Tirofiban; Tyrosine; Vasodilator Agents; Verapamil | 2014 |
The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised control
Topics: Adenosine; Clinical Protocols; Coronary Angiography; Coronary Circulation; Coronary Vessels; Humans; Magnetic Resonance Imaging; Microcirculation; Myocardial Infarction; Myocardial Perfusion Imaging; Nitroprusside; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Prospective Studies; Reperfusion Injury; Research Design; Time Factors; Treatment Outcome; United Kingdom; Vasodilator Agents | 2014 |
Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
Topics: Adenosine; Angioplasty, Balloon, Coronary; Clinical Protocols; Combined Modality Therapy; Coronary Angiography; Echocardiography; Electrocardiography; Humans; Italy; Myocardial Infarction; Nitroprusside; No-Reflow Phenomenon; Research Design; Suction; Thrombectomy; Treatment Outcome; Vasodilator Agents | 2009 |
6 other study(ies) available for adenosine and No-Reflow Phenomenon
| Article | Year |
|---|---|
No-Reflow Complicating Chronic Total Occlusion Coronary Revascularization.
Topics: Adenosine; Coronary Angiography; Coronary Circulation; Coronary Occlusion; Coronary Vessels; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Postoperative Complications; Ultrasonography, Interventional; Vasodilator Agents | 2020 |
Perforated balloon technique: A simple and handy technique to combat no-reflow phenomenon in coronary system.
Topics: Acute Coronary Syndrome; Adenosine; Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Circulation; Female; Humans; Male; Middle Aged; No-Reflow Phenomenon; Retrospective Studies; Treatment Outcome; Vasodilator Agents | 2018 |
[A high-volume single center experience of no-reflow post-percutaneous coronary intervention].
Topics: Adenosine; Aged; Female; Heart Failure; Hospitalization; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Nitroprusside; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Retrospective Studies; Ventricular Function, Left | 2014 |
Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
Topics: Adenosine; Animals; Coronary Circulation; Coronary Occlusion; Disease Models, Animal; Drug Administration Schedule; Female; Hemodynamics; Infusions, Parenteral; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; No-Reflow Phenomenon; Swine; Time Factors | 2015 |
Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice.
Topics: Acute Kidney Injury; Adenosine; Animals; Cell Line; Chimerism; Dipyridamole; Equilibrative Nucleoside Transporter 1; Humans; Ischemia; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; No-Reflow Phenomenon; Nucleoside Transport Proteins; Phosphodiesterase Inhibitors; Receptors, Purinergic P1; Regional Blood Flow | 2012 |
Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measuremen
Topics: Adenosine; Aged; Chi-Square Distribution; Contrast Media; Coronary Angiography; Coronary Circulation; Electrocardiography; Female; Humans; Linear Models; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Perfusion Imaging; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Stroke Volume; Time Factors; Treatment Outcome; Vasodilator Agents; Ventricular Function, Left | 2012 |